Research ExplorerPublicationsReview of heart-lung transplantation at Stanford

Review of heart-lung transplantation at Stanford

Standard

Review of heart-lung transplantation at Stanford. / Deuse, Tobias; Sista, Ramachandra; Weill, David; Tyan, Dolly; Haddad, Francois; Dhillon, Gundeep; Robbins, Robert C; Reitz, Bruce A.

In: ANN THORAC SURG, Vol. 90, No. 1, 07.2010, p. 329-337.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Deuse, T, Sista, R, Weill, D, Tyan, D, Haddad, F, Dhillon, G, Robbins, RC & Reitz, BA 2010, 'Review of heart-lung transplantation at Stanford', ANN THORAC SURG, vol. 90, no. 1, pp. 329-337. https://doi.org/10.1016/j.athoracsur.2010.01.023

APA

Deuse, T., Sista, R., Weill, D., Tyan, D., Haddad, F., Dhillon, G., Robbins, R. C., & Reitz, B. A. (2010). Review of heart-lung transplantation at Stanford. ANN THORAC SURG, 90(1), 329-337. https://doi.org/10.1016/j.athoracsur.2010.01.023

Vancouver

Deuse T, Sista R, Weill D, Tyan D, Haddad F, Dhillon G et al. Review of heart-lung transplantation at Stanford. ANN THORAC SURG. 2010 Jul;90(1):329-337. https://doi.org/10.1016/j.athoracsur.2010.01.023

Bibtex

@article{14e6e0625a7a452e92308a78e1eb9cd9,
title = "Review of heart-lung transplantation at Stanford",
abstract = "Long-term survival after heart-lung transplantation was first achieved in 1981 at Stanford and a total of 217 heart-lung transplantations had been performed by June 2008. This review summarizes Stanford's cumulative experience with heart-lung transplantation, demonstrates the progress that has been made, and discusses past and persistent problems. Diagnostic tools and treatment options for infectious diseases and rejection have changed and patient survival markedly improved over the almost three decades. Eight patients lived longer than 20 years. Further options to treat infections and strategies to control bronchiolitis obliterans syndrome, the main causes of early and long-term mortality, respectively, are required to achieve routine long-term survival.",
keywords = "Academic Medical Centers, Adolescent, Child, Child, Preschool, Female, Heart-Lung Transplantation/methods, Humans, Infant, Male, Middle Aged, Young Adult",
author = "Tobias Deuse and Ramachandra Sista and David Weill and Dolly Tyan and Francois Haddad and Gundeep Dhillon and Robbins, {Robert C} and Reitz, {Bruce A}",
note = "Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.",
year = "2010",
month = jul,
doi = "10.1016/j.athoracsur.2010.01.023",
language = "English",
volume = "90",
pages = "329--337",
journal = "ANN THORAC SURG",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

RIS

TY - JOUR

T1 - Review of heart-lung transplantation at Stanford

AU - Deuse, Tobias

AU - Sista, Ramachandra

AU - Weill, David

AU - Tyan, Dolly

AU - Haddad, Francois

AU - Dhillon, Gundeep

AU - Robbins, Robert C

AU - Reitz, Bruce A

N1 - Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

PY - 2010/7

Y1 - 2010/7

N2 - Long-term survival after heart-lung transplantation was first achieved in 1981 at Stanford and a total of 217 heart-lung transplantations had been performed by June 2008. This review summarizes Stanford's cumulative experience with heart-lung transplantation, demonstrates the progress that has been made, and discusses past and persistent problems. Diagnostic tools and treatment options for infectious diseases and rejection have changed and patient survival markedly improved over the almost three decades. Eight patients lived longer than 20 years. Further options to treat infections and strategies to control bronchiolitis obliterans syndrome, the main causes of early and long-term mortality, respectively, are required to achieve routine long-term survival.

AB - Long-term survival after heart-lung transplantation was first achieved in 1981 at Stanford and a total of 217 heart-lung transplantations had been performed by June 2008. This review summarizes Stanford's cumulative experience with heart-lung transplantation, demonstrates the progress that has been made, and discusses past and persistent problems. Diagnostic tools and treatment options for infectious diseases and rejection have changed and patient survival markedly improved over the almost three decades. Eight patients lived longer than 20 years. Further options to treat infections and strategies to control bronchiolitis obliterans syndrome, the main causes of early and long-term mortality, respectively, are required to achieve routine long-term survival.

KW - Academic Medical Centers

KW - Adolescent

KW - Child

KW - Child, Preschool

KW - Female

KW - Heart-Lung Transplantation/methods

KW - Humans

KW - Infant

KW - Male

KW - Middle Aged

KW - Young Adult

U2 - 10.1016/j.athoracsur.2010.01.023

DO - 10.1016/j.athoracsur.2010.01.023

M3 - SCORING: Review article

C2 - 20609821

VL - 90

SP - 329

EP - 337

JO - ANN THORAC SURG

JF - ANN THORAC SURG

SN - 0003-4975

IS - 1

ER -